A new working paper has found that one-third of all data points collected in 105 phase 2 and 3 trials were not needed for the ...
Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to ...
Povorcitinib shows promising results for hidradenitis suppurativa, offering significant lesion reduction and pain relief in ...
Cidara Therapeutics surged 250% on strong CD388 trial results and solid financials, but faces Phase 3 challenges ahead. See ...
2don MSN
BioMarin Pharmaceutical Inc.’s (BMRN) Phenylketonuria Candidate Drug Impresses in Phase 3 Trials
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best beginner stocks to buy, according to analysts. On September 6, ...
TG Therapeutics has started enrolling adults with relapsing forms of MS for a Phase 3 trial testing a subcutaneous ...
In May 2024, New Hyde Park, N.Y.-based Northwell Health and the START Center for Cancer Research — a global network of clinical trial sites — established a partnership to bring an early-stage clinical ...
Compared with placebo, a single application of the LSD-based medication MM120 is linked to rapidly reduced anxiety and ...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of best affordable biotech stocks to invest in now. Regeneron ...
MedPage Today on MSN
Higher-Dose Semaglutide Injection Proves Mettle in Phase III Trials
Tripling the weekly dose of semaglutide (Ozempic, Wegovy) resulted in greater weight loss compared with placebo in adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback